A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Animal models that closely resemble human disease can present a challenge. Particularly so in alpha-1 antitrypsin deficiency (α(1)ATD), as the mouse alpha-1 antitrypsin (α(1)AT) cluster encodes five highly related genes compared with the one in humans. The mouse PI2 homologue is closest to the α(1)AT human gene. We have changed the equivalent mouse site that results in the Z variant in man (Glu342Lys) and made both the "M" and "Z" mouse PI2 α(1)AT proteins. We have tested the ability of a small-molecular-weight compound CG to alleviate polymerisation of these mouse α(1)AT proteins as it has been shown to reduce aggregates of Z α(1)AT in man. We found that (1) CG specifically reduces the formation of polymers of recombinant mouse "Z" protein but not "M" protein; (2) whereas there is significantly more α(1)AT secreted from Chinese Hamster Ovary cells transfected with the mouse "M" α(1)AT gene than with the "Z" (20.8 ± 3.9 and 6.7 ± 3.6, respectively; P 
Original languageEnglish
Pages (from-to)241-9
JournalMammalian genome : official journal of the International Mammalian Genome Society
Volume23
Issue number3
Early online date11 Nov 2011
DOIs
Publication statusPublished - Apr 2012

Bibliographical note

Alice Turner formerly Alice Wood

Fingerprint

Dive into the research topics of 'A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency'. Together they form a unique fingerprint.

Cite this